416 related articles for article (PubMed ID: 33297569)
1. Function of TREM1 and TREM2 in Liver-Related Diseases.
Sun H; Feng J; Tang L
Cells; 2020 Dec; 9(12):. PubMed ID: 33297569
[TBL] [Abstract][Full Text] [Related]
2. Triggering Receptor Expressed on Myeloid Cells-2 Expression Tracks With M2-Like Macrophage Activity and Disease Severity in COPD.
Byers DE; Wu K; Dang-Vu G; Jin X; Agapov E; Zhang X; Battaile JT; Schechtman K; Yusen R; Pierce RA; Holtzman MJ
Chest; 2018 Jan; 153(1):77-86. PubMed ID: 29017955
[TBL] [Abstract][Full Text] [Related]
3. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells.
Hyun J; McMahon RS; Lang AL; Edwards JS; Badilla AD; Greene ME; Stone GW; Pallikkuth S; Stevenson M; Dykxhoorn DM; Kottilil S; Pahwa S; Thomas E
PLoS Pathog; 2019 Jul; 15(7):e1007883. PubMed ID: 31260499
[TBL] [Abstract][Full Text] [Related]
4. The innate immune receptor TREM-1 promotes liver injury and fibrosis.
Nguyen-Lefebvre AT; Ajith A; Portik-Dobos V; Horuzsko DD; Arbab AS; Dzutsev A; Sadek R; Trinchieri G; Horuzsko A
J Clin Invest; 2018 Nov; 128(11):4870-4883. PubMed ID: 30137027
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of triggering receptor expressed on myeloid cells-1 in the population with obesity and insulin resistance.
Subramanian S; Pallati PK; Rai V; Sharma P; Agrawal DK; Nandipati KC
Obesity (Silver Spring); 2017 Mar; 25(3):527-538. PubMed ID: 28111922
[TBL] [Abstract][Full Text] [Related]
6. Hepatic TREM2
Lee KJ; An S; Kim MY; Kim SM; Jeong WI; Ko HJ; Yang YM; Noh M; Han YH
Immunol Cell Biol; 2023 Mar; 101(3):216-230. PubMed ID: 36529983
[TBL] [Abstract][Full Text] [Related]
7. TREM2 protects against inflammation by regulating the release of mito-DAMPs from hepatocytes during liver fibrosis.
Shan S; Chao S; Liu Z; Wang S; Liu Z; Zhang C; Cheng D; Su Z; Song F
Free Radic Biol Med; 2024 Aug; 220():154-165. PubMed ID: 38710340
[TBL] [Abstract][Full Text] [Related]
8. Role of TREM1-DAP12 in renal inflammation during obstructive nephropathy.
Tammaro A; Stroo I; Rampanelli E; Blank F; Butter LM; Claessen N; Takai T; Colonna M; Leemans JC; Florquin S; Dessing MC
PLoS One; 2013; 8(12):e82498. PubMed ID: 24358193
[TBL] [Abstract][Full Text] [Related]
9. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage.
Perugorria MJ; Esparza-Baquer A; Oakley F; Labiano I; Korosec A; Jais A; Mann J; Tiniakos D; Santos-Laso A; Arbelaiz A; Gawish R; Sampedro A; Fontanellas A; Hijona E; Jimenez-Agüero R; Esterbauer H; Stoiber D; Bujanda L; Banales JM; Knapp S; Sharif O; Mann DA
Gut; 2019 Mar; 68(3):533-546. PubMed ID: 29374630
[TBL] [Abstract][Full Text] [Related]
10. TREM-1 promotes intestinal tumorigenesis.
Saurer L; Zysset D; Rihs S; Mager L; Gusberti M; Simillion C; Lugli A; Zlobec I; Krebs P; Mueller C
Sci Rep; 2017 Nov; 7(1):14870. PubMed ID: 29093489
[TBL] [Abstract][Full Text] [Related]
11. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma.
Wu J; Li J; Salcedo R; Mivechi NF; Trinchieri G; Horuzsko A
Cancer Res; 2012 Aug; 72(16):3977-86. PubMed ID: 22719066
[TBL] [Abstract][Full Text] [Related]
12. Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells.
Boudesco C; Nonneman A; Cinti A; Picardi P; Redaelli L; Swijsen S; Roewe J; Reinhardt P; Ibach M; Walter J; Pocock JM; Ren Y; Driguez PA; Dargazanli G; Eyquem S; Proto J; Flores-Morales A; Pradier L
Glia; 2022 Dec; 70(12):2290-2308. PubMed ID: 35912412
[TBL] [Abstract][Full Text] [Related]
13. TREM2 Regulates the Removal of Apoptotic Cells and Inflammatory Processes during the Progression of NAFLD.
Liebold I; Meyer S; Heine M; Kuhl A; Witt J; Eissing L; Fischer AW; Koop AC; Kluwe J; Wiesch JSZ; Wehmeyer M; Knippschild U; Scheja L; Heeren J; Bosurgi L; Worthmann A
Cells; 2023 Jan; 12(3):. PubMed ID: 36766683
[TBL] [Abstract][Full Text] [Related]
14. Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis.
Palazzo SJ; Simpson T; Schnapp LM
Dimens Crit Care Nurs; 2012; 31(1):1-6. PubMed ID: 22156803
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions.
Li Z; Wu F; Xu D; Zhi Z; Xu G
Biomed Pharmacother; 2019 Jan; 109():2014-2021. PubMed ID: 30551457
[TBL] [Abstract][Full Text] [Related]
16. Divergent Neuroinflammatory Regulation of Microglial TREM Expression and Involvement of NF-κB.
Owens R; Grabert K; Davies CL; Alfieri A; Antel JP; Healy LM; McColl BW
Front Cell Neurosci; 2017; 11():56. PubMed ID: 28303091
[TBL] [Abstract][Full Text] [Related]
17. TREM2 regulates innate immunity in Alzheimer's disease.
Li JT; Zhang Y
J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369
[TBL] [Abstract][Full Text] [Related]
18. Soluble TREM2 levels reflect the recruitment and expansion of TREM2
Hendrikx T; Porsch F; Kiss MG; Rajcic D; Papac-Miličević N; Hoebinger C; Goederle L; Hladik A; Shaw LE; Horstmann H; Knapp S; Derdak S; Bilban M; Heintz L; Krawczyk M; Paternostro R; Trauner M; Farlik M; Wolf D; Binder CJ
J Hepatol; 2022 Nov; 77(5):1373-1385. PubMed ID: 35750138
[TBL] [Abstract][Full Text] [Related]
19. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.
Radsak MP; Salih HR; Rammensee HG; Schild H
J Immunol; 2004 Apr; 172(8):4956-63. PubMed ID: 15067076
[TBL] [Abstract][Full Text] [Related]
20. Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma.
Zhang L; Qu X; Xu Y
Front Immunol; 2024; 15():1324010. PubMed ID: 38370418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
